Skip to content
Monday, 9 November 2026Malta edition Enquire Malta-24 Briefing @CDNewsDispatch
Malta's world news feed Local perspective with global outlook
CDE.NEWS The Dispatch
Enquire
LATEST
Poland in shock: six dead, 15 wounded in Krakow Main Square shooting Malta beat Germany 37-29 in Rugby Trophy thriller Why Malta Should Abstain on the EU Tobacco Excise Directive Kremlin Claims Divided Europe Lacks Clear Voice for Ukraine Peace Talks Wave of bomb threats afflict European flights for third time this week
EU Commission

Vaccines: contract between European Commission and AstraZeneca now published

cde.news desk · 1 min read
Xinf
A person holds printed copies of the 42-page contract between the European Commission and AstraZeneca for the production, purchase and supply of a COVID-19 vaccine in the EU, in front of the European Commission in Brussels, Belgium, 29 January 2020. The European Commission on 29 January 2021 published a redacted version of the contract between the EU Commission and Anglo-Swedish biopharmaceutical company AstraZeneca over the purchase of Covid-19 vaccine doses, following their dispute over delivering less than allegedly agreed on. The EU and AstraZeneca disagree over parts of the contract, which have been blacked out in the published redacted version. EPA-EFE/STEPHANIE LECOCQ

Following the renewed request from the European Commission on 27 January 2021, pharmaceutical company AstraZeneca has agreed to publish the redacted contract signed between the two parties on 27 August 2020.

The Commission welcomes the company’s commitment towards more transparency in its participation in the rollout of the EU Vaccines Strategy.

Transparency and accountability are important to help build the trust of European citizens and to make sure that they can rely on the effectiveness and safety of the vaccines purchased at the EU level.

The Commission hopes to be able to publish all contracts under the Advance Purchase Agreements in the near future.

The contract published today contains redacted parts pertaining to confidential information such as details of invoices. The AstraZeneca contract is the second one to be published, after CureVac has agreed to publish the Advance Purchase Agreement with the European Commission.

Filed under Comuniq.EUEU CommissionEuropean Commission
Topics AstraZenecacommissionCovid-19 Vaccination

More from EU Commission

More →
EU Commission

EU to focus on housing needs in year ahead – EC President

 EU Commission

European Commission disburses €237 million in pre-financing to Latvia

 EU Commission

EU Humanitarian Air Bridge to deliver emergency aid to Haiti following earthquake